Chunchun Yuan

Chunchun Yuan

Auto-generated profile, based on publicly available information

Chunchun Yuan

Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2022 in Phenomics
Verified
Journal Article
Open access
PDF file
CYChunchun Yuan
Chunchun Yuan
WZWeiqiang Zhang
Weiqiang Zhang
JWJing Wang
Jing Wang
CHChen Huang
Chen Huang
BSBing Shu
Bing Shu
YWYong-jun Wang
Yong-jun Wang
The systematicness of phenomics and Traditional Chinese Medicine (TCM) enable these two disciplines to interlink with each other. This article discussed the similarity in theory and application between TCM and phenomics and illustrates their respective advantages in diagnosis and treatment of diseases, forming a new discipline eventually. Chinese medicine phenomics (Chinmedphenomics) is built on classic TCM, combined with phenomics technology, and the development of which needs the mega cohort with TCM syndrome and the characteristics of precision medicine as well as multi-disciplinary cooperation, which is personalized, precise and promising, providing unique scientific insights into understanding human health.

12 March 2024 in Cell Discovery
Verified
Journal Article
Open access
PDF file
CYChunchun Yuan
Chunchun Yuan
XYXiang-Tian Yu
Xiang-Tian Yu
JWJing Wang
Jing Wang
BSBing Shu
Bing Shu
XWXiao-Yun Wang
Xiao-Yun Wang
YWYong-jun Wang
Yong-jun Wang
Due to a rapidly aging global population, osteoporosis and the associated risk of bone fractures have become a wide-spread public health problem. However, osteoporosis is very heterogeneous, and the existing standard diagnostic measure is not sufficient to accurately identify all patients at risk of osteoporotic fractures and to guide therapy. Here, we constructed the first prospective multi-omics atlas of the largest osteoporosis cohort to date (longitudinal data from 366 participants at three time points), and also implemented an explainable data-intensive analysis framework (DLSF: Deep Latent Space Fusion) for an omnigenic model based on a multi-modal approach that can capture the multi-modal molecular signatures (M3S) as explicit functional representations of hidden genotypes. Accordingly, through DLSF, we identified two subtypes of the osteoporosis population in Chinese individuals with corresponding molecular phenotypes, i.e., clinical intervention relevant subtypes (CISs), in which bone mineral density benefits response to calcium supplements in 2-year follow-up samples. Many snpGenes associated with these molecular phenotypes reveal diverse candidate biological mechanisms underlying osteoporosis, with xQTL preferences of osteoporosis and its subtypes indicating an omnigenic effect on different biological domains. Finally, these two subtypes were found to have different relevance to prior fracture and different fracture risk according to 4-year follow-up data. Thus, in clinical application, M3S could help us further develop improved diagnostic and treatment strategies for osteoporosis and identify a new composite index for fracture prediction, which were remarkably validated in an independent cohort (166 participants).

14 February 2023 in Phenomics
Verified
Journal Article
Closed access
PDF file
STSiyuan Tu
Siyuan Tu
YYYu-lian Yin
Yu-lian Yin
CYChunchun Yuan
Chunchun Yuan
HCHongfeng Chen
Hongfeng Chen

1 June 2024 in Phenomics
Verified
Journal Article
Open access
PDF file
JJJiangxun Ji
Jiangxun Ji
FCFeihong Cai
Feihong Cai
CYChunchun Yuan
Chunchun Yuan
CHChen Huang
Chen Huang
HZHaitao Zhang
Haitao Zhang
YWYong-jun Wang
Yong-jun Wang
The link between gut microbiota (GM) and primary osteoporosis has garnered substantial attention. In this study, we conducted a systematic review encompassing 10 studies that employed high-throughput sequencing methodologies. Notably, the taxonomic profiles exhibited pronounced heterogeneity across reviewed studies. A combined analysis of mechanistical studies screened out potential targets for osteoporosis prevention and treatment. We appraised the limitations in previous studies, and proposed suggestions for optimizing sequencing techniques and experimental designs. Larger-size longitudinal cohorts based on multi-omics and extended phenotypes are recommended to comprehensively characterize the involvement of GM in the pathogenesis of osteoporosis.

28 May 2026 in Aging Cell
Verified
Journal Article
Open access
PDF file
FWFeng‐Ao Wang
Feng‐Ao Wang
TZTao Zeng
Tao Zeng
CYChunchun Yuan
Chunchun Yuan
HWHongyu Wang
Hongyu Wang
YYYule Yu
Yule Yu
YLYixue Li
Yixue Li
Aging is a global issue that affects human health and increases disease risk. The traditional concept of the “age gap (AG),” defined as the difference between estimated biological age and an individual's chronological age, has been used for self‐monitoring the risk of age‐related diseases. However, the current AG does not account for the stratified aging patterns across different stages of chronological age, which may lead to biased or paradoxical interpretations of aging acceleration. To address these limitations, we propose Personalized‐context‐Aware Age Gap (PAAG), a robust metric to estimate aging acceleration, based on our new pre‐training model AOE‐Net (Age Order Enhanced Network). AOE‐Net employs age‐order enhanced contrastive learning on multi‐omics data from healthy populations to learn latent representations that accurately reconstruct aging trajectories by capturing biological deviation rather than technical deviation in omics data. We demonstrate that PAAG, generated via fine‐tuning AOE‐Net, significantly outperforms AG of conventional first‐ and second‐generation aging clocks in predicting clinical outcomes. This superior predictive power was validated across diverse age‐related diseases and phenotypes: pan‐cancer (overall survival), subclinical atherosclerosis (PESA score), and osteoporosis (bone mineral density). Crucially, PAAG serves as a context‐aware metric that may improve the clinical outcome prediction of existing aging clocks. Furthermore, interpretive analysis of PAAG's molecular drivers revealed a strong functional enrichment for immune‐response pathways, providing a shared mechanistic link between accelerated aging and disease. Collectively, PAAG could serve as a stable indicator of aging acceleration for clinically assessing age‐related diseases, and AOE‐Net provides an effective pre‐training model for aging study and PAAG evaluation.